TIDMJIL
RNS Number : 5527R
Juridica Investments Limited
30 April 2009
Juridica Investments Limited ("JIL" or the "Company")
Results for the period ended 31 December 2008
30 April 2009
Juridica, the leading provider of capital to the law market, today announces its
audited financial results for the period ended 31 December, 2008.
Financial highlights
* Over $112 million deployed in 18 claim assets invested or committed over the
period in 19 claim assets across 12 investments;
* Success rate of 100% to date for cases reaching final determination;
* Gross profit of $5.19 million generated over the period from two litigation
investments that reached final determination;
* Early returns and currency gain resulted in NAV growth of 30%, to 194.4c
(130.6p) per ordinary share at 31 December 2008;
* Approved interim dividend of 4.6p paid on 24 April 2009; and
* Successful secondary placing at 114p per share raising of GBP33.2 million
completed during April 2009 - funds available to deploy in new investment
opportunities.
Operational highlights
* Assembled network of high quality law and finance professionals to help JCML
underwrite, structure and monitor JIL's investments;
* Established advisory network to evaluate investments and design
ethically-compliant structures;
* Firmly established JIL in the US and UK markets for law finance by building
market awareness and an established pipeline of deal flow; and
* Deployed capital in a diverse portfolio of investments, with expectations of
steady returns on investment over time.
Commenting on the results, Juridica's Chairman, Lord Daniel Brennan QC, said:
"We have had a fantastic first year in which the Company has performed beyond
its own demanding expectations. Juridica has met with considerable demand and
its disciplined approach to case analysis has already yielded a respectable
dividend ahead of expectations. Juridica is well on the way to becoming the
premier law finance company."
Richard Fields, Chief Executive Officer, Juridica Capital Management Limited,
commented:
"We face a pipeline of high quality new opportunities competing for investment
capital. The appetite for our services continually strengthens as a market in
need of over US$33 billion annually chases a limited amount of available
capital. To capture these opportunities we have established a sustainable and
scalable business model and will continue to invest in situations which offer
attractive returns for our shareholders.
"The current economic environment has increased the demand for capital and we
will continue to offer funding packages which provide access to strong cases and
offer high quality returns."
For more information contact:
+--------------------------------------------+---------------------------+
| Juridica Capital Management Limited | +1 986 6443 1080 |
| Richard W. Fields | |
| | |
+--------------------------------------------+---------------------------+
| Cenkos Securities plc | +44 20 7397 8900 |
| Nicholas Wells | |
| Camilla Hume | |
| | |
+--------------------------------------------+---------------------------+
| Bell Pottinger Corporate & Financial | +44 20 7861 3232 |
| David Rydell | |
| Olly Scott | |
| | |
+--------------------------------------------+---------------------------+
Notes to Editors
Juridica Investments Limited is a limited liability, closed-ended investment
company registered in Guernsey, that commenced trading on AIM, a market operated
by the London Stock Exchange, on 21 December 2007.
The Company is building a diversified portfolio of investments in claims and
aims to provide shareholders with an attractive level of dividends and capital
growth through investing directly and indirectly in litigation and arbitration
cases, claims and disputes.
The ultimate goal of the Company is to be a leading source of value-added and
direct financing for large claims in complex litigation and arbitration
worldwide where such financing is considered to be lawful and permitted under
local law and rules on professional ethics.
For more information visit Juridica Investments Limited at
http://www.juridicainvestments.com/ and Juridica Capital Management Limited at
http://www.juridica.co.uk/
Juridica Investments Limited ("JIL" or the "Company")
Results for the period ended 31 December 2008
30 April 2009
Chairman's Statement
In my role as Chairman of the Board of Juridica Investments Limited ("JIL" or
the "Company"), I am pleased to present the Company's maiden results. The
Company's fund manager, Juridica Capital Management Limited ("JCML" or the
"Manager"), started operations in the closing weeks of December 2007 and, over
the course of the first year, established a solid team, developed its systems
and underwriting guidelines and built a diversified portfolio of claims and
litigation assets that is impressive for both its size and quality. The
portfolio offers investors the advantages of an alternative asset class that is
expected to have a low correlation to overall economic conditions. Although the
Company is at a relatively early stage in its development, the portfolio has
performed well relative to most other asset classes in a year of unprecedented
global economic turmoil. This report covers trading from the date of
incorporation (28 November 2007) to 29 April 2009, and the results below cover
trading to 31 December 2008.
Highlights from the 17 months to 29 April 2009 include the following:
* JIL invested or committed a substantial portion of its capital (over $112
million) in 19 claim assets across 12 investments;
* The Company earned early returns from three investments in litigation cases that
finished successfully and generated a gross profit of $6.41 million on its
investments;
* None of the investments in claims or cases have failed to date, so the Company's
success ratio at this early stage is 100%;
* The Company's conservative approach to currency risk (discussed in more detail
below) resulted in a substantial currency gain for Sterling investors as
Sterling depreciated relative to the US dollar;
* For Sterling investors, the early returns and currency gain resulted in
significant annual growth in the NAV of the portfolio, which had increased by
30% to 130.6p per ordinary share at 31 December 2008;
* The Company paid a dividend to shareholders on 24 April 2009 of 4.6p (6.7c) per
share, yielding 4.6% on the issue price at admission;
* A successful placing at 114p per share to raise $48.4 million (GBP33.2 million)
net of expenses was completed in April 2009, increasing funds available for new
investment opportunities; and
* In a market that saw the collapse of share prices for many AIM-listed companies
and funds, the Company's share price closed the year up 10% at 110p per ordinary
share.
Results for the Period to 31 December 2008
Income
During the period to 31 December 2008, the Company reported total income of
$11.7 million. This included realised gains of $5.1 million representing
realised gains on two investments, unrealised accrued income of $2.5 million,
and interest income of $4.1 million. Unrealised gains represent the effective
interest rate on the Company's disbursements to date, calculated in accordance
with the Company's accounting policies. These interest rates are derived from
the Manager's estimate of expected outcomes of its investments in the absence of
an established market for the Company's assets. Since the year end, one further
investment has been realised for a net profit of $1.22 million.
Costs
Over the course of the year the Company spent $1.44 million on due diligence and
other transaction costs, representing 1.3% of the value of the Company's
investments or commitments over the period to 31 December 2008.
Over the reporting period, the Company reviewed its position on currency
holdings and determined that it was most appropriate for the predominance of
cash holdings to be dollar denominated.
The Company transferred almost half its assets into dollars soon after launch
and the balance in May 2008. Although a modest realised currency loss was
reported as at 31 December 2008, this was significantly offset by the
appreciation of the US dollar against Sterling over the reporting period. In
response to the significant uncertainty facing the banking system, the Company
held short-dated US treasury instruments between June 2008 and 31 December 2008
and, as a result, suffered loss of interest income but no loss of capital.
As at 31 December 2008 the Company had $82.5 million of cash or cash equivalents
including $78.4 million in dollar denominated holdings and the balance in
Sterling.
Over the period, the Company reported net income of $2.4 million which resulted
in a net asset value of 190.44c (130.6p) per ordinary share, a net increase of
30.6% in Sterling terms on the Company's initial issue price.
The Portfolio
Since our last detailed announcement to shareholders on 8 March 2009, one case
(Case 0908-U) involving a claim against a sovereign was settled. On 20 March
2009, JIL received a return of $4.3 million on an investment of $3.1 million
made on 7 July 2008 yielding an internal rate of return of 71%.
As at 29 April 2009, the Company's portfolio included investments giving
exposure to 13 active litigation cases and an additional three investments in
patents that are not currently in litigation but are or will be pursued through
licensing enforcement/settlement programs prior to litigation. The litigation
cases include 4 competition cases (two monopolisation cases and two price-fixing
cases), one statutory claim, 4 patent cases, two property damage and insurance
subrogation cases, one shareholder dispute and one arbitration case involving a
sovereign through the International Centre for Sovereign Investment Disputes
(ICSID) organised by The World Bank. The total capital invested or committed by
the Company on 29 April 2009 was a maximum of $93.25 million (excluding the
three settled cases). Of the total amount committed or invested, $62 million was
loaned to Fields Scrantom Sullivan PLLC to allow it to finance the 4 competition
cases and one statutory claim, approximately $25.1 million is exposed to patent
litigation and licensing enforcement activities, $3.5 million relates to an
international arbitration (ICSID) case, $2.2 million is committed to funding
shareholder dispute litigation, and $0.5 million is invested in entitlements to
two property damage and subrogation claims.
Outlook
My fellow Directors and I would like to take this opportunity to thank investors
for the confidence they have shown in Juridica Investments Limited. We were
especially pleased with the number of original shareholders who participated in
the Company's recent placing and we welcome our new shareholders to what we hope
and expect will be an exciting second year for the business. The challenging
market environment has accelerated interest in the Company's business model and
increased requests for financing from companies, and major law firms and their
clients in the US, the UK and elsewhere. The Company is well on its way to
establishing market leadership in the growing claims asset class. We will be
working closely again this year with the Manager to meet the Company's
objectives for dividend income, NAV growth and commensurate share price
performance.
Lord Daniel Brennan QC
Chairman
Investment Manager's Report
Our first full year of operations at Juridica Capital Management Limited
("JCML") was both exciting and challenging. The challenges came from an
ambitious set of goals that we established for ourselves focused on building a
diversified portfolio of investments in commercial cases and claims. The key
objectives we established for this first full year of operations included:
* Building a solid team of law and finance professionals to help us underwrite,
structure and monitor JIL's investments;
* Building a network of legal and ethics experts to help us evaluate case
investments and design ethically-compliant investment structures;
* Establishing awareness of JIL in the legal market among Am Law 200 firms (the
200 largest commercial law firms in the US) and global law firms in the UK;
* Deploying a substantial portion of JIL's capital in a diverse portfolio of
opportunities; and
* Investing in a group of relatively mature cases that could generate early
returns for our shareholders while demonstrating the strength of the business
model and the nature of opportunities in this market.
We believe we made substantial progress toward achieving all of these goals.
Excitement came from our early returns on three investments (through 29 April
2009), and from the surprising pace at which the market welcomed our business
model and demonstrated an interest in our product offerings. Since 21 December
2007, we have reviewed 140 cases and made investments providing exposure to 17
active litigation cases (three cases realised) and an additional three
patent-related matters that are not currently in litigation but will be pursued
through licensing enforcement/settlement programs prior to litigation. We made
substantial progress in developing scalable underwriting systems and processes
for the evaluation of claims and continue to refine these. Relationships have
been established with major law firms and advisor groups that are leaders in the
markets that are key to our portfolio. These firms contributed to a steady
stream of potential investment opportunities for JIL. A substantial portion of
JIL's capital is now committed to a group of investments that we believe is
diverse across an important range of variables and has a relatively low
correlation to market conditions. We have made major progress in establishing
JIL as a market leader in both the US and the UK through directing marketing
efforts and widespread press coverage. In addition, as part of its intention to
analyse litigation finance in the US and the UK, RAND Corporation's Institute
for Civil Justice invited JCML to be a member of its Board of Overseers.
Highlights
JIL was admitted to AIM, a market operated by the London Stock Exchange, during
December 2007 with an initial market capitalisation of GBP80 million. Since
Admission, JIL has invested or committed $112.25 in commercial claims and
litigation cases. JIL earned a gross profit of $6.41 million (to 29 April 2009)
on early returns in three investments in litigation cases that finished
successfully. None of the investments in claims or cases have failed to date, so
the Company's success ratio at this early stage is 100%. JIL's Net Asset Value
as at 31 December 2008 was 130.6 pence (in Sterling), an increase of 30.6% since
launch. Our share price was 121 pence on 29 April 2009, an increase of 21% since
launch. An interim dividend of 4.6 pence (6.7068c) was paid on 24 April 2009,
and GBP33.2 million (net of expenses) was raised simultaneously from existing
and new shareholders.
Market Size and Competition
The American Lawyer 200 ("Am Law 200") is a leading index of US law firms
compiled by the magazine The American Lawyer. Its 2008 survey of the 200 largest
commercial law firms in the US indicated this group earned aggregate revenues of
$81.5 billion. Applying percentages from a survey of litigation revenue for this
group conducted by The Lawyer magazine in 2007, total litigation revenues for
these top firms were estimated to be in excess of $33 billion during 2008.
During an economic recession and certainly during this one, litigation revenues
can be expected to increase as a percentage of a firm's total revenues. Of
course, not all the cases represented by this revenue are available for
investment by external capital, but this is a very large market indeed.
UK global law firms and US Am Law 200 firms are under economic stress as a
result of the credit crisis and ensuing recession. Traditional sources of hourly
billing in the corporate and transactional business have diminished, leading law
firms to cut lawyers and staff at a rate never seen in the modern legal market.
Furthermore, general counsels of major companies are under pressure to cut legal
expenses, particularly where there is discretion to do so - as in cases where
the company is bringing a lawsuit as opposed to defending one. Law firms and
general counsels alike are expressing increased interest in alternative fee
structures and risk financing opportunities. This has had a positive impact on
interest in financing from JIL and other sources.
Though the market for commercial litigation and claims is quite large, JIL's
competition remains limited. In the US, we have one major competitor for claims
investment generally, a large global financial institution that is pursuing the
objective of building a diversified portfolio of commercial claims. We have
participated in one syndicated investment with this competitor and have
developed a positive working relationship with their team. We have also
encountered a small group of hedge funds, a Japanese bank, an insurer and a few
high net worth individuals (mostly successful trial lawyers) that have invested
in cases as third parties. In addition, there are several funds and investment
companies that invest exclusively in the intellectual property claim field.
Market conditions however are believed to have severely restricted this group's
access to capital for investments in claims, and we know of only a limited
number of hedge funds actively seeking investments in this asset class. In the
UK, competitors were numerous in early 2008, but by the end of the year, we
believe only an insurer and a few smaller companies were well financed and
actively pursuing development of a portfolio of claims. Other hedge fund
investors are doing so only on an ad hoc basis. However, we expect to see more
competitors in the UK market as economic conditions stabilise. Notwithstanding
our very capable competitors in both the US and the UK, we believe that JIL has
a significant opportunity to become the pre-eminent capital provider to the
legal market.
Profile of a Lawsuit
The majority of JIL's portfolio is invested in US cases and claims. In most US
jurisdictions, once a complaint has been filed there are four key phases of a
lawsuit; early motions, discovery, summary judgment and trial, followed by
appeals (if any). In a typical case, early jurisdictional decisions and motions
to dismiss the case are followed by a lengthy, expensive period of discovery,
during which both plaintiff and defendant seek information and documents in
order to assess the risk of liability and the potential quantum of damages.
During or after this period, the plaintiff and/or defendant(s) file motions for
summary judgment to be decided by a judge on the "undisputed facts" of a case.
This results in either the case being dismissed or the plaintiff's case being
significantly strengthened or weakened. After summary judgment rulings, the case
is set for trial, usually by jury. Post-trial motions to attack the result and
appeals sometimes follow. This outline, though emblematic of the "typical" case,
is rare because most commercial cases in the US never proceed to trial. The
large majority of cases are settled or dismissed on the merits prior to trial.
Cash settlement may occur even if a case is dismissed. Unsurprisingly, the
larger the case the more likely it is that it will be resolved prior to trial.
Although settlement can take place at any time, including before a lawsuit is
filed, settlement events are expected to occur around key court decisions:
following early motions, after contentious discovery disputes, after summary
judgment motions, and in the period just prior to trial. In our experience, the
single most important driver of settlement is the trial date. Trial dates are
often moved - sometimes more than once in a single case - but the presence of a
trial date focuses the wallets and the minds of the parties on resolution.
The Cost of Litigation
Plaintiff
The cost of litigating a commercial case with potential damages from $25 million
or more may run from a few million to tens of millions. The cost of litigation
in the US is often proportional to the size of the dispute, as the parties are
willing to spend more as the level of risk increases. This cost may be split
between significant third-party vendors and expenses, including expert analysis
of the issues as well as normal legal fees of the lawyers. The risk of the
transaction costs for a commercial case (legal fees, experts and disbursements)
are often shared with the plaintiff's counsel acting on a contingent basis. A
plaintiff's attorney will typically charge between 20% and 40% of the recovery
in the case in return for a reduced hourly rate, a capped fee, a percentage of
the recovery, or some combination of all these features.
Defendant(s)
The cost of defending a similar sized commercial case often matches the cost of
prosecution, depending on jurisdiction and complexity. This cost is almost
always paid on an hourly basis, but may often be shared where multiple
defendants have been sued.
Litigation Strategy
The aim of a commercially-aware plaintiff's lawyer is to resolve the dispute
between plaintiff and defendant in a manner that generates the highest possible
recovery for the client, given the client's particular tolerance for risk.
Understanding the value of a claim and the likelihood of settlement thereby
requires examining the incentives, financial or otherwise, of all parties
involved in a dispute; and it is this context, with all of its complexity and
relationships, that offers the most insight into the value and timing of
settlement. More often than not, cases are settled during the litigation process
rather than decided by trial. Many general counsels believe that very few cases
should ever be tried given the unpredictability of juries deciding complex
commercial disputes. We agree with them. The credible threat of a large award at
trial is usually the driving factor behind settlement negotiations. Discovery,
the various pre-trial motions and the summary judgment rulings should serve to
clarify the merits and corresponding value of a case prior to trial and
encourage settlement. For this reason, selection of the court or forum is also a
key component of strategy. Plaintiffs pay particular attention to the track
record of the judges and juries in various jurisdictions, and this often has a
significant impact on where cases are filed. Early motions by defendants often
challenge the plaintiff's selection of the forum, sometimes on multiple grounds,
in an attempt to move the case to a slower or more defendant-friendly
jurisdiction.
Multi-defendant strategies in commercial litigation
Many commercial cases involve claims against multiple defendants. Although the
existence of multiple defendants may somewhat increase the cost of litigation
for the plaintiff and mitigate that cost for defendants who arrange to share
costs, these cases offer the client (and therefore the investor) a natural hedge
against outright loss as they provide opportunities to fund the costs of
litigation through settling with one or more defendants at an early stage for a
discount. A typical strategy would be to settle with smaller defendants (in
terms of liability share and/or ability to pay) prior to settlements with larger
defendants. This has two advantages. Firstly, it helps as a practical matter to
set a 'floor' on damages for later settlements. Secondly the case, as an
investment opportunity, is significantly de-risked by income from early
settlements. This is a classic "divide and conquer" strategy used by
sophisticated plaintiff's lawyers in all kinds of litigation, including complex
commercial litigation.
Particularly in cases that involve potential joint and several liability for
defendants, like price-fixing cartel cases, the presence of multiple defendants
limits credit risk. In the current economic climate, we place a lot of
importance on this.
The Portfolio Allocation
On 29 April 2009, the JIL portfolio included the investments in the table below.
+-------------------------------------------+---------+-+------------+-+-------------+
| Type of litigation | Cases | |Commitment | |Investments |
+-------------------------------------------+---------+-+------------+-+-------------+
| Antitrust (monopolisation) | 2 | | | | |
+-------------------------------------------+---------+-+------------+-+-------------+
| Antitrust (price fixing) | 2 | | $62.0m | | 1 |
+-------------------------------------------+---------+-+------------+-+-------------+
| Statutory Claims | 1 | | | | |
+-------------------------------------------+---------+-+------------+-+-------------+
| Patents | 4 | | $25.05m | | 5 |
+-------------------------------------------+---------+-+------------+-+-------------+
| Property damage and insurance subrogation | 2 | | $0.5m | | 1 |
+-------------------------------------------+---------+-+------------+-+-------------+
| Claims against sovereigns | 1 | | $3.5m | | 1 |
+-------------------------------------------+---------+-+------------+-+-------------+
| Shareholder disputes | 1 | | $2.2m | | 1 |
+-------------------------------------------+---------+-+------------+-+-------------+
| | | | | | |
+-------------------------------------------+---------+-+------------+-+-------------+
| | 13 | | $93.25m | | 9 |
+-------------------------------------------+---------+-+------------+-+-------------+
The portfolio has the following features:
* $112.25 million invested or committed since Admission ($92.25 million net of 3
resolved cases that yielded a gross profit of $6.41 million)
* Number of claims in pre-litigation settlement programs: 3
* Certain investments include ancillary rights to finance future cases
* Number of subject matters: 7
* Number of jurisdictions/fora: 10
* Number of plaintiff law firms: 11
* Average exposure per case opportunity: $8.0 million
Key Schedule Dates in Invested Cases
+-----------+--------------------------------------------------------------+
| 0108-S | Trial date scheduled for Q4 2011 |
+-----------+--------------------------------------------------------------+
| 0408-P | Trial date scheduled for Q4 2009, although this may be |
| | delayed |
+-----------+--------------------------------------------------------------+
| 0608-S | Claimant's reply to be filed in Q1 2009 |
+-----------+--------------------------------------------------------------+
| | Hearing date scheduled for Q3 2009 |
+-----------+--------------------------------------------------------------+
| 0708-B | Trial date expected Q1 2012 |
+-----------+--------------------------------------------------------------+
| 0808-C(1) | Trial date scheduled for Q1 2010 |
+-----------+--------------------------------------------------------------+
| 0808-C(2) | Trial date scheduled for Q1 2011 |
+-----------+--------------------------------------------------------------+
| 0908-U | Cash has been received |
+-----------+--------------------------------------------------------------+
| 1608-T | Resolutions subject to court supervision of division of |
| | settlement proceeds |
+-----------+--------------------------------------------------------------+
| | among multiple claimants |
+-----------+--------------------------------------------------------------+
| 6308-F | Soft licensing program begins in Q1 2009 |
+-----------+--------------------------------------------------------------+
| 1208-A | Settlement mediation scheduled for Q2 2009 |
+-----------+--------------------------------------------------------------+
| | Jury trial scheduled for Q3 2009 |
+-----------+--------------------------------------------------------------+
| 5208-E | Hearing on jurisdictional issues scheduled for Q2 2009 |
+-----------+--------------------------------------------------------------+
| 5308-U | Defendants' answers to be filed in Q2 2009 |
+-----------+--------------------------------------------------------------+
| 5608-N | Fact discovery closed in Q1 2009 |
+-----------+--------------------------------------------------------------+
| | Expert discovery closes in Q4 2009 |
+-----------+--------------------------------------------------------------+
| | Hearing on dispositive motions in Q4 2010 |
+-----------+--------------------------------------------------------------+
| 1008-A | Trial date scheduled for Q4 2009, although this may be |
| | delayed |
+-----------+--------------------------------------------------------------+
Selected Commitments in 2008
Antitrust/Competition Litigation
In November 2008, JIL loaned Fields Scrantom Sullivan PLLC ("FSS") $62 million
and FSS entered into a partnership with a premier US antitrust practice (
"Antitrust Group"). The Antitrust Group is litigating a portfolio of 5 existing
cases (the "Initial Portfolio"). As part of the loan arrangements, JIL and its
affiliates are entitled to 12% interest on a promissory note and a 36% interest
on a credit guarantee swap with FSS. The Antitrust Group is entitled to
contingency fees between 12% and 20% of settlements from the Initial Portfolio.
Damages sought in the Initial Portfolio are in excess of $8 billion, although
settlement values are expected to be considerably lower than the damages sought.
Antitrust litigation is brought in the US under the Sherman Act or the Clayton
Act and carries the possibility of statutory treble damages for the defendants.
In the UK, these cases are brought under the EU competition laws, which impose
the risk of interest on damage awards. Because these are large cases with
significant risk for most defendants, the cases are expensive and complicated,
and involve highly sophisticated experts. Historically, antitrust litigation is
financed in the US by the plaintiff's lawyers' balance sheets, with many law
firms involved for multiple plaintiffs and multiple defendants.
The price-fixing cases are particularly attractive investment opportunities for
JIL as they are perceived to have a low risk profile and high potential damages.
Civil litigation in this arena often, but not always, follows either criminal
prosecution by the US Department of Justice or early settlement by a cartel
member in exchange for giving evidence against co-conspirators. These events
help to establish liability. The multi-defendant nature of these cases increases
the likelihood of pre-trial settlements.
The monopoly cases are also attractive investment opportunities for JIL because
of the potential for large recoveries through settlement or damage awards. These
cases have a higher risk profile because of added complexity but we still view
them as low to moderate risk investments with large potential recoveries.
We expect the loan to FSS to be extended as more antitrust cases are developed
in 2009.
Patent Litigation and Claims
JIL has invested in 4 patent litigation cases and three groups of additional
patents that are not in litigation but will be pursued through licensing
enforcement/settlement programs prior to litigation. Patents are assets upon
which the US federal government grants a limited-period monopoly to an
inventor(s). Similar to property, a patent may be sold, licensed, mortgaged,
assigned or transferred. Patent rights may be enforced by civil action in the
United States federal courts. If the court determines that the patent is valid
and has been infringed by the defendants, it may grant the defendant a license
to that patent, and damages to the patent holder. The value of the license is
typically a proportion of overall historic and expected revenue earned by the
plaintiff on the infringing product.
A number of well-funded participants are engaged in this very specialised area
of the law finance market. In addition to JIL, these include Rembrandt, Acacia,
Altitude Capital and other hedge funds. A team of ex-Microsoft executives at
Intellectual Ventures is believed to have raised more than $1.0 billion to
acquire patent portfolios.
During 2008, we identified multiple opportunities to acquire patents outright
for litigation. It also became evident that the cost of patent litigation was
often significantly higher than the purchase price of a patent or portfolio of
related patents. In addition, we identified multiple law firms that are willing
to take the best of these cases on pure contingency fee basis and carry risk of
the litigation, occasionally including the cost of experts and third party
disbursements. We also identified market participants that have been successful
in monetising patents by settlement prior to litigation through licensing
programs. We organised Turtle Bay Technologies Limited ("TBT") in December of
2008 as a wholly owned subsidiary of JCML to take advantage of these market
characteristics.
TBT gives JIL an opportunity to fund the purchase price of patent assets for
significantly less than the cost of litigation and to retain a much larger
equity stake in the outcome of litigation or settlement activities for less
money. In addition, by purchasing patents outright or the majority equity stake
in a patent and using law firms that assist in settlement or prosecute
litigation on a pure contingency fee basis, these particular investments have a
much lower risk profile. In 2009, we expect to make further investments in
patents through TBT. These investments will be structured so that 100% of
investment returns are paid to JIL under a funding agreement.
Outlook for 2009
For the remainder of 2009, we will be focused on expanding our network of law
firms that present opportunities for investment to JIL. In addition, we will
begin the first phase of an effort to increase awareness of JIL among leading
General Counsels of Fortune 500 companies.
We will also be evaluating potential opportunities to hedge risk in the
portfolio through insurance and co-investment/syndication opportunities. Most
importantly, we will continue to look for great opportunities to expand the JIL
portfolio through investment of the additional capital raised during March 2009.
Richard W. Fields
CEO, Juridica Capital Management Limited
Statement of Directors' Responsibilities in Respect of the Financial Statements
The directors are responsible for preparing financial statements for the period
which give a true and fair view of the state of affairs of the Group as at the
end of the financial period and of the Consolidated Income Statement of the
Group for that period in accordance with The Companies (Guernsey) Law, 2008. In
preparing these financial statements, the directors are required to:
* select suitable accounting standards and then apply them consistently;
* make judgements and estimates that are reasonable and prudent;
* state whether applicable accounting standards have been followed subject to any
material departures disclosed and explained in the financial statements; and
* prepare the financial statements on the going concern basis unless it is
inappropriate to presume that the company will continue in business.
The directors confirm that they have complied with the above requirements in
preparing the financial statements.
The directors are responsible for keeping proper accounting records which
disclose with reasonable accuracy at any time the financial position of the
Company and to enable them to ensure that the financial statements have been
properly prepared in accordance with The Companies (Guernsey) Law, 2008. They
are also responsible for safeguarding the assets of the Company and hence for
taking reasonable steps for the prevention and detection of fraud and other
irregularities.
To the best of our knowledge, and in accordance with the applicable reporting
principles, the consolidated financial statements give a true and fair view of
the assets, liabilities, financial position and profit or loss of the Group,
although there is uncertainty around valuation of the Company's claim assets in
the absence of an established market. The Investment Manager's report includes a
fair review of the development and performance of the business and the position
of the Group, together with a description of the principal opportunities and
risks associated with the expected development of the Group.
Independent Auditor's Report
We have audited the consolidated financial statements of Juridica Investments
Limited for the period ended 31 December 2008 which comprise the Consolidated
Income Statement, the Consolidated Balance Sheet, the Consolidated Statement of
Changes in Equity, the Consolidated Cash Flow Statement and the related notes.
These financial statements have been prepared under the accounting policies set
out therein.
Respective responsibilities of directors and auditors
The directors' responsibilities for preparing the consolidated financial
statements in accordance with applicable Guernsey law and International
Financial Reporting Standards are set out in the Statement of Directors'
Responsibilities.
Our responsibility is to audit the consolidated financial statements in
accordance with relevant legal and regulatory requirements and International
Standards on Auditing (UK and Ireland). This report, including the opinion, has
been prepared for and only for the Company's members as a body in accordance
with Section 262 of The Companies (Guernsey) Law, 2008 and for no other purpose.
We do not, in giving this opinion, accept or assume responsibility for any other
purpose or to any other person to whom this report is shown or into whose hands
it may come save where expressly agreed by our prior consent in writing.
We report to you our opinion as to whether the financial statements give a true
and fair view and are properly prepared in accordance with The Companies
(Guernsey) Law, 2008. We also report to you whether in our opinion the
information given in the Directors' Report is consistent with the consolidated
financial statements.
In addition we report to you if, in our opinion, the Group has not kept proper
accounting records or if we have not received all the information and
explanations we require for our audit.
We read the other information contained in the Annual Report and consider the
implications for our report if we become aware of any apparent misstatements or
material inconsistencies with the consolidated financial statements. The other
information comprises only the Corporate Information, the Chairman's Statement,
the Investment Manager's Report and the Directors' Report and the Notice of
Annual General Meeting
Basis of audit opinion
We conducted our audit in accordance with International Standards on Auditing
(UK and Ireland) issued by the Auditing Practices Board. An audit includes
examination, on a test basis, of evidence relevant to the amounts and
disclosures in the consolidated financial statements. It also includes an
assessment of the significant estimates and judgements made by the directors in
the preparation of the consolidated financial statements, and of whether the
accounting policies are appropriate to the Group's circumstances, consistently
applied and adequately disclosed.
We planned and performed our audit so as to obtain all the information and
explanations which we considered necessary in order to provide us with
sufficient evidence to give reasonable assurance that the consolidated financial
statements are free from material misstatement, whether caused by fraud or other
irregularity or error. In forming our opinion we also evaluated the overall
adequacy of the presentation of information in the consolidated financial
statements.
Opinion
In our opinion:
* the consolidated financial statements give a true and fair view, in accordance
with International Financial Reporting Standards, of the state of the Group's
affairs as at 31 December 2008 and of its profit and cash flows for the period
then ended;
* the consolidated financial statements have been properly prepared in accordance
with The Companies (Guernsey) Law, 2008; and
* the information given in the Directors' Report is consistent with the
consolidated financial statements.
Emphasis of Matter
Without qualifying our opinion, we draw attention to Notes 2(h), 3(i) and 13(i)
to the consolidated financial statements. As indicated in Notes 2(h), 3(i) and
13(i), the consolidated financial statements include non-current assets stated
at their fair value of US$69,951,765. Because of the inherent uncertainty
associated with the valuation of such non-current assets and the absence of a
liquid market, these fair values may differ from their realisable values, and
the differences could be material.
PRICEWATERHOUSECOOPERS CI LLP
Chartered Accountants
Guernsey, Channel Islands
30 April 2009
Consolidated Income Statement
period from 28 November 2007 to 31 December 2008
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| | | Period from | |
+-----------------------------------------+-----------------------------------------+-------------------------------------+----------+
| | | 28 November | |
+-----------------------------------------+-----------------------------------------+-------------------------------------+----------+
| | | 2007 to | |
+-----------------------------------------+-----------------------------------------+-------------------------------------+----------+
| | | 31 December | |
+-----------------------------------------+-----------------------------------------+-------------------------------------+----------+
| | | 2008 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| INCOME | Notes | USD | |
+ +-----------------------------------------+-------------------------------------+----------+
| | | | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Interest income | 2(h) | 4,092,740 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Realised gain on investments | 5 | 5,190,276 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Realised loss on investments | | (44,696) | |
+-----------------------------------------+-----------------------------------------+-------------------------------------+----------+
| Other income | 5, 6 | 2,501,186 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| | | | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Total income | | 11,739,506 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| EXPENSES | | | | |
+ +-----------------------------------------+--------------------------+----------+----------+
| | | | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Accountancy | | 7,598 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Administration fees | | 249,703 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| | | | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Advisory fees | | 105,684 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Asset Management Fees | | 33,307 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Audit fees | | 172,221 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Bank charges | | 33,267 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Directors remuneration | 10(g) | 463,165 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Due diligence costs | 2(f) | 567,095 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Foreign exchange loss | | 3,377,009 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Legal expenses | | 19,464 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Licence fees | | 4,696 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Management fee | 10(a) | 3,685,644 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Marketing expenses | | 24,047 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Options and warrants costs | 2(p) | 274,734 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Registrars fee | | 15,382 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Sundry expenses | | 261,724 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| | | | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| TOTAL EXPENSES | | 9,294,740 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Profit for the period | | | | |
+ +-----------------------------------------+--------------------------+----------+----------+
| | | 2,444,766 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Profit per Ordinary Share | | | | |
+ +-----------------------------------------+--------------------------+----------+----------+
| | | | | |
+ +-----------------------------------------+--------------------------+----------+----------+
| | | | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Basic | | 3.06 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
| Fully diluted | | 3.01 | | |
+-----------------------------------------+-----------------------------------------+--------------------------+----------+----------+
The notes following form an integral part of these consolidated financial
statements including the Independent Auditors' report above
Consolidated Balance Sheet
as at 31 December 2008
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| | | 2008 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| | Notes | USD | |
+--------------------------------------------+--------------------------------------------+----------------------------------+----------+
| Non-current assets | | | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Available for sale financial assets | 5 | 16,518,357 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Loans and receivables | 6 | 53,433,408 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| | | 69,951,765 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Current assets | | | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Other receivables and prepayments | 7 | 273,785 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Cash and cash equivalents | 8 | 82,511,937 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| | | 82,785,722 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Total assets | | 152,737,487 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Current liabilities | | | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Other payables | 9 | 383,972 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Total liabilities | | 383,972 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Net assets | | 152,353,515 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Capital and reserves | | | | |
+ +--------------------------------------------+-----------------------+----------+----------+
| | | | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Special reserve | | 150,169,960 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Other reserve | | (261,211) | |
+--------------------------------------------+--------------------------------------------+----------------------------------+----------+
| Revenue reserve | | 2,444,766 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Total equity Shareholders' funds | | 152,353,515 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Number of ordinary shares | | | | |
+ +--------------------------------------------+-----------------------+----------+----------+
| | | 80,000,000 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
| Net Asset value per ordinary share | | | | |
+ +--------------------------------------------+-----------------------+----------+----------+
| | | $1.9044 | | |
+--------------------------------------------+--------------------------------------------+-----------------------+----------+----------+
The notes following form an integral part of these consolidated financial
statements including the Independent Auditors' report above
Consolidated Statements of Changes in Equity
period from 28 November 2007 to 31 December 2008
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| | | Share | | Special | Other | Revenue | | | | |
+--------------------+--------------------+-------------------+---------+-------------------+-------------------+-----------+---------+----------+----------+----------+
| | | premium | | reserve | reserve | reserve | | Total | |
+--------------------+--------------------+-------------------+---------+-------------------+-------------------+-----------+---------+---------------------+----------+
| | | USD | | USD | USD | USD | | USD | |
+--------------------+--------------------+-------------------+---------+-------------------+-------------------+-----------+---------+---------------------+----------+
| Net assets at | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| 28 November 2007 | | - | | - | - | - | | - | |
+--------------------+--------------------+-------------------+---------+-------------------+-------------------+-----------+---------+---------------------+----------+
| Issue of shares | 158,488,000 | | | - | - | - | 158,488,000 | | |
+--------------------+------------------------------+---------+---------+-------------------+-------------------+-----------+--------------------+----------+----------+
| Formation costs | (8,318,040) | | - | - | - | (8,318,040) | |
+--------------------+----------------------------------------+---------+-------------------+-------------------+-----------+-------------------------------+----------+
| Cancellation of | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| share premium | (150,169,960) | 150,169,960 | | - | - | | - | |
+--------------------+----------------------------------------+-------------------+---------+-------------------+-----------+---------+---------------------+----------+
| Share option | | | | | | | | | | | | | |
| payment | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| reserve | | - | | - | 27,828 | | - | 27,828 | | |
+--------------------+--------------------+-------------------+---------+-------------------+---------+---------+-----------+--------------------+----------+----------+
| Warrant payment | | - | | - | 246,906 | | - | 246,906 | | |
| reserve | | | | | | | | | | |
+--------------------+--------------------+-------------------+---------+-------------------+---------+---------+-----------+--------------------+----------+----------+
| Fair value change | | | | | | | | | | | | | |
| in | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| available for sale | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| financial assets | | - | | - | (535,945) | - | (535,945) | |
+--------------------+--------------------+-------------------+---------+-------------------+-------------------+-----------+-------------------------------+----------+
| Profit for the | | - | | - | - | 2,444,766 | 2,444,766 | | |
| period | | | | | | | | | |
+--------------------+--------------------+-------------------+---------+-------------------+-------------------+-----------+--------------------+----------+----------+
| Net assets at | | | | | | | | | | | | | |
+ +--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| 31 December 2008 | | - | 150,169,960 | | (261,211) | 2,444,766 | 152,353,515 | | |
+--------------------+--------------------+-------------------+-------------------+---------+-------------------+-----------+--------------------+----------+----------+
| | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
| | | | | | | | | | | | | | |
+--------------------+--------------------+---------+---------+---------+---------+---------+---------+---------+-----------+---------+----------+----------+----------+
The notes following form an integral part of these consolidated financial
statements including the Independent Auditors' report above.
Consolidated Cash Flow Statement
period from 28 November 2007 to 31 December 2008
+-------------------------------------------------+------------------+----------+----------+----------+
| | | Period from | |
+-------------------------------------------------+------------------+---------------------+----------+
| | 28 November 2007 | |
+-------------------------------------------------+----------------------------------------+----------+
| | to 31 December 2008 | |
+-------------------------------------------------+----------------------------------------+----------+
| | | USD | |
+-------------------------------------------------+------------------+---------------------+----------+
| Cash flows from operating activities | | | | |
+-------------------------------------------------+------------------+----------+----------+----------+
| Profit for the period | 2,444,766 | | |
+-------------------------------------------------+-----------------------------+----------+----------+
| Adjusted for: | | | | |
+-------------------------------------------------+------------------+----------+----------+----------+
| Fair value change on financial assets and loans | (2,439,315) | |
| and receivables | | |
+-------------------------------------------------+----------------------------------------+----------+
| Changes in working capital | | | | |
+-------------------------------------------------+------------------+----------+----------+----------+
| Increase in other receivables and prepayments | (273,785) | |
+-------------------------------------------------+----------------------------------------+----------+
| Increase in trade and other payables | 383,972 | | |
+-------------------------------------------------+-----------------------------+----------+----------+
| Increase in share option and warrant reserve | 274,734 | | |
+-------------------------------------------------+-----------------------------+----------+----------+
| Realised gain on financial assets | (5,190,276) | |
+-------------------------------------------------+----------------------------------------+----------+
| Net cash outflow from operating activities | | | ) | |
+ +------------------+----------+ +----------+
| | | (4,799,904 | | |
+-------------------------------------------------+-------------------------------------------------+------------------+----------+----------+
| Cash flows from investing activities | | | | |
+ +------------------+----------+----------+----------+
| | (80,108,119) | |
+-------------------------------------------------+ +----------+
| Purchases of financial assets and loans and | | |
| receivables | | |
+-------------------------------------------------+-------------------------------------------------------------------------------+------------------+
| Sales of financial assets | 17,250,000 | | |
+-------------------------------------------------+-----------------------------+----------+----------+
| Net cash used in investing activities | | | ) | |
+ +------------------+----------+ +----------+
| | | (62,858,119 | | |
+-------------------------------------------------+-------------------------------------------------+------------------+----------+----------+
| Financing activities | | | | |
+ +------------------+----------+----------+----------+
| | | | | |
+-------------------------------------------------+-------------------------------------------------+------------------+----------+----------+
| Issue of shares | 158,488,000 | | |
+-------------------------------------------------+-----------------------------+----------+----------+
| Formation costs | (8,318,040) | |
+-------------------------------------------------+----------------------------------------+----------+
| Net cash inflow from financing activities | | | | |
+ +------------------+----------+----------+----------+
| | | 150,169,960 | | |
+-------------------------------------------------+-------------------------------------------------+------------------+----------+----------+
| Net increase in cash and cash equivalents | | | | |
+ +------------------+----------+----------+----------+
| | | 82,511,937 | | |
+-------------------------------------------------+-------------------------------------------------+------------------+----------+----------+
| Cash and cash equivalents at start of period | | - | |
+-------------------------------------------------+------------------+---------------------+----------+
| Cash and cash equivalents at 31 December 2008 | 82,511,937 | | |
+-------------------------------------------------+-----------------------------+----------+----------+
| | | | | |
+-------------------------------------------------+------------------+----------+----------+----------+
| | | | | |
+-------------------------------------------------+------------------+----------+----------+----------+
The notes following form an integral part of these consolidated financial
statements including the Independent Auditors' report above
Notes to the Consolidated Financial Statements
period from 28 November 2007 to 31 December 2008
1.LEGAL FORM AND PRINCIPAL ACTIVITY
The Group consists of the Company which is a closed-ended investment company
incorporated under The Companies (Guernsey) Law, 2008 (the "Law") and its wholly
owned subsidiary Riverbend Investments Limited, a non-cellular company within
the meaning of section 2(1)(c) of the Law, incorporated under the Law. The Law
does not make a distinction between private and public companies. Shares in the
Company were admitted to trading on AIM, a market operated by the London Stock
Exchange, on 21 December 2007. The address of the Company's registered office is
Bordeaux Court, Les Echelons, St Peter Port, Guernsey, GY1 6AW.
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of the financial
statements are set out below.
(a) Basis of preparation
The consolidated financial statements of the Group have been prepared in
accordance with International Financial Reporting Standards (IFRS) and all
applicable requirements of The Companies (Guernsey) Law, 2008. They have been
prepared under the historical cost convention, as modified by the revaluation of
available for sale financial assets. The preparation of financial statements in
conformity with IFRS require the use of certain critical accounting estimates.
It also requires The Board of Directors to exercise its judgement in the process
of applying the Group's accounting policies. The areas involving a degree of
judgement or complexity, or areas where assumptions and estimates are
significant to the financial statements are disclosed in Note 3.
i. Interpretations effective in 2008 but not relevant:
IFRS 11 IFRS 2-Group and share transactions;
IFRS 12 Service concession arrangements; IFRS 13 Customer loyalty programmes;
and
IFRS 14 IAS 19-The limit on a defined benefit asset, minimum funding
requirements and their interaction.
ii. Standards, amendments and interpretations to existing standards that are
not yet effective and have not been early adopted by the group:
IAS 1 (revised), Presentation of financial statements (effective from 1 January
2009);
IFRS 1 (amendment), First time adoption of IFRS and IAS 27, Consolidated and
separate financial statements (effective from 1 January 2009);
IAS 27 (revised), Consolidated and separate financial statements (effective from
1 July 2009);
IFRS 5 (amendment), Non-current assets held for sale and discontinued operations
(effective from 1 July 2009);
IAS 36 (amendment), Impairment of assets (effective from 1 January 2009);
IAS 39 (amendment), Financial instruments; Recognition and measurement
(effective from 1 January 2009);
IAS 1 (amendment), Presentation of financial statements (effective from 1
January 2009);
(b) Consolidation
The consolidated financial statements comprise the financial statements of
Juridica Investments Limited and its wholly owned subsidiary undertaking as
stated in Note 4.
Subsidiaries
Subsidiaries are all entities (including special purpose entities) over which
the group has the power to govern the financial and operating policies generally
accompanying a shareholding of more than one half of the voting rights. The
existence and effect of potential voting rights that are currently exercisable
or convertible when assessing whether the Group controls another entity.
Subsidiaries are fully consolidated from the date on which control is
transferred to the Group. They are de-consolidated from the date that control
ceases. The purchase method of accounting is used to account for the acquisition
of subsidiaries by the Group.
Inter-company transactions, balances and unrealised gains/losses on transactions
between group companies are eliminated. Accounting policies of subsidiaries have
been changed where necessary to ensure consistency with the policies adopted by
the Group.
(c) Geographical and segment reporting
Since the Group is engaged in the provision of similar products and services
within a particular economic environment, being subject to similar risks and
returns, the management considers that the Group has only one business segment
and geographical focus, being investments in legal claims in the US, and
accordingly does not present additional business and geographical segment
information.
(d) Financial instruments
i. Classification
Unless otherwise determined by the Company, investments in claims will be
categorised as available for sale financial instruments. The investments in
claims will initially be measured as the cash sum provided to acquire an
interest in a plaintiff's claim or as the cash advanced to law firms under loan
agreements ("Qualifying Agreements"). Due diligence costs are capitalised into
the cost of the investment.
ii. Recognition, derecognition and measurement
Regular purchases and sales of available for sale financial instruments are
recognised on the trade date, being the date on which the Company commits to
purchase or sell the asset.
The investments in claims will initially be measured as the cash sum provided to
acquire an interest in a plaintiff's claim or as the cash advanced to law firms
under loan agreements ("Qualifying Agreements").
Interest on performing investments in claims will be recognised using the
effective interest rate method as explained in Note 5. No interest will be
recognised on non-performing investments in claims.
Subsequent measurement of investments in claims will be at fair value utilising
a fair value model developed by the Manager. The principal assumptions to be
used in the fair value model are as follows:
* Risk free rate of loan interest;
* Duration of each investment in a claim;
* Best estimate of anticipated outcome; and
* Effective interest rate on nominal value of each investment in a claim.
Movements in fair value arising from changes in assumptions related to each
legal claim will be taken to the Consolidated Income Statement. Movements in
market based assumptions, due to market, credit and interest risk, will be taken
directly to equity and only recognised in the Consolidated Income Statement on
finalisation of the claim.
iii. Fair value estimation
Fair value will be reviewed quarterly on an individual investment basis. Events
that will trigger changes to the fair value of each investment in a claim
include the following;
* Changes in general US dollar interest rate assumptions (market assumption);
* Successful judgement in a claim in which the Company has an investment;
* Unsuccessful disposition or judgement in a claim in which the Company has an
investment;
* Outstanding appeals against both successful and unsuccessful judgements;
* An investment in a claim is to be sold at a discount or premium, or to be
settled out of Court by a binding agreement;
* Legal impediments to collectibility of claims (in the US Chapter 7 Bankruptcy or
Chapter 11 Court Protection from Creditors); and
* An investment in a case that is dismissed with predjudice (meaning, it can never
be re-filed anywhere).
(e) Loans and receivables
Loans and receivables entered into by the Company will initially be measured as
the cash sum advanced to a law firm. Due diligence costs are capitalised into
the cost of the investment. Subsequent measurement of loans and receivables
will be at amortised cost using the effective interest rate method.
(f)Due diligence costs
The due diligence costs attributable to cases that have resulted in an
investment have been capitalised into the cost of the investment. Any other due
diligence costs not directly relating to a claim investment have been expensed
immediately.
(g) Foreign currency translation
i. Functional and presentation currency
Items included in the financial statements of each of the Group's entities are
measured using the currency of the primary economic environment in which the
entity operates ("the functional currency"). The functional currency of the
Group as determined in accordance with IFRS is the United States Dollar because
this is the currency that best reflects the economic substance of the underlying
events and circumstances of the Group. The consolidated financial statements are
presented in US Dollars, the presentation currency.
ii. Transactions and balances
Foreign currency transactions are translated into the functional currency using
the exchange rate prevailing at the dates of the transactions. Foreign exchange
gains and losses resulting from the settlement of such the transactions and from
the translation at period-end exchange rates of monetary assets and liabilities
denominated in foreign currencies are recognised in the Consolidated Income
Statement.
(h) Interest income
Interest income for all performing available for sale instruments and cash and
cash equivalents is recognised in the Consolidated Income Statement on an
accruals basis, using the effective interest rate method.
The effective interest rate method is a way of calculating the amortised cost of
a financial asset and of allocating the interest income over the relevant
period. In the case of assets this rate is the rate that takes the contract's
initial value to the expected payout over the expected duration of the asset.
The application of the method has the effect of recognising estimated income on
the instrument evenly in proportion to the amount outstanding over the period to
maturity or repayment.
In calculating effective interest, the Company estimates cash flows (using
projections based on litigation experience and due diligence evaluations)
considering all contractual terms and the likely outcome of the case. This
impacts on the effective interest rate applied to contracts as seen in Notes
3(i), 5 and 13(i).
(i)Cash and cash equivalents
Cash and cash equivalents includes cash in hand, deposits held at call with
banks and other short-term highly liquid investments with original maturities of
three months or less.
(j)Taxation
The Company has obtained exempt company status in Guernsey. The Company is,
therefore, only liable to an annual exemption fee of GBP600.
With effect from 1 January 2008 the exempt company regime was, for the most
part, abolished and the standard rate of income tax in Guernsey moved from 20%
to 0%, however, Collective Investment Schemes remain eligible to apply for
exemption status. The Directors intend to conduct the Group's affairs such that
the Company will remain eligible for exemption.
To the extent that any foreign witholding taxes or any form of profits taxes
become payable, these will be accrued on the basis of the event that created the
liability to taxation.
(k) Expenses
Expenses are accounted for on an accruals basis. Expenses for monitoring claims
will generally be paid by the Manager except in extraordinary circumstances
approved by the Board of Directors of the Company.
(l)Dividends
Dividends paid during the period will be disclosed in equity. A final dividend
proposed by the Board and approved by the shareholders prior to the period end
will be disclosed as a liability. Dividends proposed and not approved will be
disclosed in the notes.
(m) Other receivables and prepayments
These are recognised at fair value, less provision for impairments for
non-recoverable amounts.
(n) Other payables
These are recognised at fair value.
(o) Share capital
Ordinary shares are classified as equity. Incremental costs directly
attributable to the issue of new shares is shown in equity as a deduction from
the proceeds.
(p) Share-based payments transactions
The Company engages in equity settled share-based payment transactions in
respect of the services received from one of its directors and from Cenkos
Securities ("Nominated Adviser and Broker") as set out in the Company's
Admission Document. The fair value of the services received is measured by
reference to the fair value of the shares or share options granted on the date
of the grant. The fair value of the share options is recognised in the
Consolidated Income Statement over the period that the services are received,
which is the vesting period. The fair value of the options granted is determined
using the Black-Scholes option pricing model, which takes into account the
exercise price of the option, the current share price, the risk free interest
rate, the expected volatility of the share price over the life of the option and
other relevant factors. Except for those which include terms to market
conditions, vesting conditions included in the terms of the grant are not taken
into account in estimating the fair value.
Non market vesting conditions are taken into account by adjusting the number of
shares or share options included in the measurement of the cost of the services
so that ultimately, the amount recognised in the Consolidated Income Statement
reflects the number of vested shares or share options. Where vesting conditions
are related to market conditions, the charges for the services received are
recognised regardless of whether or not the market conditions related vesting
condition is met, provided that the non-market vesting conditions are met. The
assumptions used to determine the fair values are, a risk free interest rate per
annum of 2.993% which has been based on the UK FTSE Gilt Indicies as at 31
December 2008 and a volatility rate of 15% per annum which has been determined
using a price-weighted index of other companies with some similar
characteristics to the Company.
(q) Impairment of assets
The carrying amounts of assets are assessed on a quarterly basis to determine
whether there is any indication of impairment. If such indication exists, the
Company estimates the recoverable amount of the asset, being the higher of the
assets net selling price and its value in use. Any impairment loss is recognised
for the decline of the assets' recoverable amount below its carrying value and
the difference being taken to the Consolidated Income Statement.
3.CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS
Critical accounting estimates and assumptions
The Manager makes estimates and assumptions concerning the future. The resulting
accounting estimates will, by definition, seldom equal the related actual
results. The estimates and assumptions that have a significant risk of causing a
material adjustment to the carrying amounts of assets and liabilities within the
next financial year are outlined below.
i. Critical accounting judgements in applying the Company's accounting policies
In the process of applying the Company's accounting policies, which are
described in Note 2, the Directors have relied upon the Manager's assessment of
claim investments including the probability of success on the merits of each
claim, likelihood of settlement and claim duration. This is most evident in the
assessment of the effective interest rate applied to contracts entered into by
the Company, as disclosed in Note 5 below.
ii. Determination of functional currency
The determination of the functional currency of the Company is critical since
recording of transactions and exchange differences arising there from are
dependent on the functional currency selected. As described in Note 2, the
Directors have considered those factors described therein and have determined
that the functional currency of the Company is the United States Dollar (US$).
4.INVESTMENT IN SUBSIDIARY
2008 USD
Riverbend Investments Limited1
During the period, the Company owned 100% of the ordinary shares of Riverbend
Investments Limited, a Company incorporated on 8 October 2008, in Guernsey,
Channel Islands.
+--+-----------------------+-----------------+------------+--+--------+--+-----------+----------+------------+----------+
| 5.| AVAILABLE FOR SALE FINANCIAL ASSETS | | | | | | | |
+--+------------------------------------------------------+--+--------+--+-----------+----------+------------+----------+
| | | | | | | | | | 2008 | |
+--+-----------------------+-----------------+------------+--+--------+--+-----------+----------+------------+----------+
| Investments in claims | | | | | | | | USD | |
+--------------------------+-----------------+------------+--+--------+--+-----------+----------+------------+----------+
| | | | | | | | / | | |
+--+-----------------------+-----------------+------------+--+--------+--+ +------------+----------+
| | | | | | | | | | |
+--+-----------------------+-----------------+------------+--+--------+--+----------------------+------------+----------+
| | | | | | | | | | |
+--+-----------------------+-----------------+------------+--+--------+--+----------------------+------------+----------+
| Case reference | Opening balance | Additions | | Disposals | Fair value | Closing | |
| | | | | | movement due to | balance | |
| | | | | | effective | | |
| | | | | | interest | | |
+--------------------------+-----------------+------------+--+-----------+----------------------+------------+----------+
| 0108-S | - | 1,054,149 | | - | 17,839 | | 1,071,988 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| 0208-G (settled) | - | 12,050,211 | (13,750,000) | 1,699,789 | | - | |
+--------------------------+-----------------+------------+--------------+-----------+----------+------------+----------+
| 0308-R (settled) | - | 9,513 | (3,500,000) | 3,490,487 | | - | |
+--------------------------+-----------------+------------+--------------+-----------+----------+------------+----------+
| 0408-W | - | 1,085,784 | | - | 70,654 | | 1,156,438 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| 0608-S | - | 1,496,091 | | - | 63,124 | | 1,559,215 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| 0708-B | - | 678,109 | | - | 29,071 | | 707,180 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| 0808-C | - | 3,444,102 | | - | 138,775 | | 3,582,877 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| 0908-U | - | 3,119,371 | | - | 1,200,000 | | 4,319,371 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| 1608-T | - | 480,513 | | - | 37,966 | | 518,479 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| 6308-F | - | 1,189,757 | | - | 13,047 | | 1,202,804 | |
+--------------------------+-----------------+------------+--+-----------+-----------+----------+------------+----------+
| | | | | | | | | | |
+--------------------------+-----------------+------------+--+--------+--+-----------+----------+------------+----------+
| Sub total Investments in | | 24,607,600 | (17,250,000) | 6,760,752 | | 14,118,352 | |
| claims | | | | | | | |
+--------------------------+-----------------+------------+--------------+-----------+----------+------------+----------+
| Investment in Juridica | | | | | | (535,945) | | |
| Capital | | | | | | | | |
+--------------------------+-----------------+------------+--+--------+--+ +------------+----------+
| | Management Limited | - | 2,935,950 | | - | | 2,400,005 | |
+--+-----------------------+-----------------+------------+--+-----------+----------------------+------------+----------+
| | | | | | | | | | |
+--------------------------+-----------------+------------+--+--------+--+-----------+----------+------------+----------+
| At 31 December 2008 | | 27,543,550 | (17,250,000) | 6,224,807 | | 16,518,357 | |
+--------------------------+-----------------+------------+--------------+-----------+----------+------------+----------+
| | | | | | | | | | | |
+--+-----------------------+-----------------+------------+--+--------+--+-----------+----------+------------+----------+
Claim investments have been accounted for using the effective interest method of
calculation. Effective interest rates on these investments ranged between 3.62
and 100.14 percent at 31 December 2008. At 31 December 2008 the Company had
invested in eleven claims. Two of these claims had been determined at 31
December 2008 resulting in a profit on the investment of $5,190,276.
The fair value of the Company's investment in Juridica Capital Management
Limited was assessed as at 31 December 2008 to be $2,400,005, a change in value
of ($535,945).
Further details on the sensitivity of the Company's asset value to assumptions
in the effective interest rate are detailed in Note 13.
+----+---------------+---------------+------------+-----------+-----------+------------+----------+
| 6. | LOANS AND RECEIVABLES | | | | | |
+----+-------------------------------+------------+-----------+-----------+------------+----------+
| | | | | | | 2008 | |
+----+---------------+---------------+------------+-----------+-----------+------------+----------+
| | | | | | | USD | |
+----+---------------+---------------+------------+-----------+-----------+------------+----------+
| | | | | Mo | | | |
+----+---------------+---------------+------------+-----------+ +------------+----------+
| | | | | | | | |
+----+---------------+---------------+------------+-----------+-----------+------------+----------+
| | | | | | | | |
+----+---------------+---------------+------------+-----------+-----------+------------+----------+
| Case reference | Opening | Drawdown | Repayment | Movement | Closing | |
| | balance | | | due to | balance | |
| | | | | effective | | |
| | | | | interest | | |
+--------------------+---------------+------------+-----------+-----------+------------+----------+
| 3608-A | - | 52,564,569 | - | 868,839 | 53,433,408 | |
+----+---------------+---------------+------------+-----------+-----------+------------+----------+
Note 13(f) details arrangements between the Group and FSS. The Loan and the swap
have been aggregated on consolidation and treated as a single claim asset.
Returns on the loan and the swap are dependant on returns in claims financed by
FSS. As detailed in Note 13, there remains risk that there is considerable
variability in possible outcomes and the effective interest rate will not be as
expected.
+----+----------------------------------------------------------------+----------+----------+
| 7. | OTHER RECEIVABLES | 2008 | |
+----+----------------------------------------------------------------+ +----------+
| | | | |
+----+----------------------------------------------------------------+----------+----------+
| | | USD | |
+----+----------------------------------------------------------------+----------+----------+
| Debtors | 72,755 | |
+---------------------------------------------------------------------+----------+----------+
| Accrued Interest | 201,030 | |
+---------------------------------------------------------------------+----------+----------+
| | | | |
+----+----------------------------------------------------------------+----------+----------+
| | | 273,785 | |
+----+----------------------------------------------------------------+----------+----------+
| | | | |
+----+----------------------------------------------------------------+----------+----------+
+-------------------------------------------------------------------+------------+
| 8.CASH & CASH EQUIVALENTS | |
+-------------------------------------------------------------------+------------+
| | 2008 |
+-------------------------------------------------------------------+------------+
| | USD |
+-------------------------------------------------------------------+------------+
| Treasury Bills | 21,608,129 |
+-------------------------------------------------------------------+------------+
| Cash at Bank | 60,903,808 |
+-------------------------------------------------------------------+------------+
| | |
+-------------------------------------------------------------------+------------+
| | 82,511,937 |
+-------------------------------------------------------------------+------------+
| | |
+-------------------------------------------------------------------+------------+
For the purpose of the Cash Flow Statement, the above items represent the period
end cash and cash equivalents.
+----+----------------------------------------------------------------+---------+
| 9. | CURRENT LIABILITIES | |
+----+----------------------------------------------------------------+---------+
| | | 2008 |
+----+----------------------------------------------------------------+---------+
| | | USD |
+----+----------------------------------------------------------------+---------+
| Sundry Creditors | 225,363 |
+---------------------------------------------------------------------+---------+
| Legal and Professional Fee | 43,734 |
+---------------------------------------------------------------------+---------+
| Audit Fees | 114,875 |
+---------------------------------------------------------------------+---------+
| | |
+---------------------------------------------------------------------+---------+
| Commitments | 383,972 |
+---------------------------------------------------------------------+---------+
| | | |
+----+----------------------------------------------------------------+---------+
Under the terms of some of its investment contracts, JIL provides a line of
credit to counterparties. As at 31 December 2008, the maximum commitment under
these lines of credit was $27.5 million.
10. RELATED PARTY TRANSACTIONS
The principals of Juridica Capital Management Limited are Richard Fields and
Timothy Scrantom. Each of Tim Scrantom and Richard Fields, Directors of JCML,
acquired 50,000 Ordinary Shares in the Company (0.0625 per cent. equity interest
each) as reimbursement of 100,000 pounds Sterling of pre IPO costs.
(a) Management fee
The Company is managed by Juridica Capital Management Limited, an investment
management company incorporated in Guernsey in which the Company holds a 15
percent equity interest. Under the terms of the Management Agreement, the
Company appointed Juridica Capital Management Limited as an Manager to provide
management services to the Company. The Manager receives a fee based on the
adjusted net asset value of the Company, payable quarterly in advance using the
annual rate of 2.5 percent. The adjusted net asset value is the net asset value
of the Company at the relevant time, after accruing for the annual management
fee but not taking into account any liability of the Company for accrued
performance fees and after;
(i) deducting any unrealised gains on investments, (ii) adding the amount of any
write downs with respect to investments which have not been written off and
(iii) deducting the value of the Company's investment in JCML. The Investment
Management fee for 2008 is based upon the Net Asset Value of the Company
immediately after listing which was $147,234,010. In the period to 31 December,
2008 management fees totalling $3,685,644 were paid to Juridica Capital
Management Limited. As at 31 December the management fee creditor was $ Nil.
(b) Investment in Juridica Capital Management Limited
The Company acquired 15 percent of Juridica Capital Management Limited on
Admission. The investment is measured at fair value. An impairment review has
been performed as part of the fair value assessment and an impairment review
will be carried out on an annual basis.
(c) Performance fee
The Manager is entitled to a performance fee based on the adjusted net asset
value (being the NAV of the Company before taking into account any performance
fee payable less any unrealised gains on investments plus the value of any
writedowns in any investments that have been written down but not written off)
of the Company. The performance fee will equal 20 percent of the annualised
increase in the net asset value between a hurdle rate of 8 percent and 20 per
cent, furthermore a fee of 35 percent of the increase between a hurdle of 20
percent and 40 percent and 50 percent of the same increase over a hurdle of
below 40 percent. The fees are subject to a high water mark such that no
performance fee will be paid if the performance of the Company does not exceed
the net asset value at the end of the previous year in which the performance fee
was paid. Payment of the performance fee is subject to the condition set out in
(d), below. For the purposes of calculating the performance fee at 31 December
2008, the adjusted net asset value was:
+------------------------------------------------------------------+-------------+----------+
| | As at |
+------------------------------------------------------------------+------------------------+
| | 31 Dec 2008 |
+------------------------------------------------------------------+------------------------+
| Net asset value | 152,353,515 | |
+------------------------------------------------------------------+-------------+----------+
| Less fair value movement in available for sale assets and loan | (2,439,315) |
| to FSS | |
+------------------------------------------------------------------+------------------------+
| Less carrying value of investment in JCML | (2,400,005) |
+------------------------------------------------------------------+------------------------+
| | | |
+------------------------------------------------------------------+-------------+----------+
| Adjusted net asset value | 147,514,195 | |
+------------------------------------------------------------------+-------------+----------+
| | | |
+------------------------------------------------------------------+-------------+----------+
As at 31 December 2008, the hurdle rate was not achieved, therefore, no
performance fee was paid or payable for the period.
(d) Trust account
Of the performance fee, 50 percent of any payment within the first four years
from the date of Admission will be retained by the Company in a trust account.
During that period if, at any given year end, the annualised increase in net
asset value of the Company is less than 8 percent, the Company may claw back 20
percent of the difference between the actual net asset value and the net asset
value assuming an 8 percent increase from the net asset value for the previous
period. As at 31 December 2008, the balance in the trust account was $Nil.
(e) On 20 November 2008, the Company agreed to provide $1.475 million to
FaceVu LLC, a company not related to the Company. $525,000 of this will be paid
to Turtle Bay Technologies Limited, a company ultimately owned and controlled by
Juridica Capital Management Limited, for services to be provided to FaceVu by
Turtle Bay Technologies Limited.
(f) Facility agreement and Collateral Account
The Company has entered into a facility agreement (the "Facility") with which it
agrees to loan to Fields Scrantom Sullivan PLLC ("FSS") money for funding cases
in which FSS is to act under a Co-counsel Agreement. The Company expects to
enter into loan arrangements with other law firms (which may
include other
law firms established by the Principals) on terms and conditions similar to
those contained
in the Facility. The Facility available to FSS will be for
up to approximately 50 percent of the net proceeds
of the capital raised
less any loans made to other law firms. The Facility will remain outstanding and
available until the earlier of (i) termination of the Management Agreement, (ii)
the date on which
Richard Fields and Tim Scrantom cease to own a controlling
interest in FSS, (iii) the winding up of the Company, an event of default of the
Facility documents, or (v) ten years from Admission. Under the Facility
drawdowns may be requested by FSS from time to time up to the maximum principal
amount, but subject always to approval by the Company in its sole discretion.
No more than $10 million may be drawn down in respect of the same case
investment (unless the Board agrees).
The Company agreed to loan FSS $62 million at a compounding annual interest rate
of 12 percent pursuant to a loan agreement and promissory note (the "Note"). The
Note and the Swap have superseded the Facility, although the principal terms
remain. At 31 December 2008, $52 million had been drawn down. The Loan and Note
are repayable over 10 years and are secured by FSS's economic interests in the
Partnership and outcomes of the initial portfolio of cases. In light of the fact
that the Loan and Note are with recourse to FSS (but not the FSS members) at the
end of the term of the Loan, FSS has entered into a swap agreement with
Riverbend Investments Limited ("Riverbend"), a wholly-owned subsidiary of JIL
(the "Swap").
Under the Swap, Riverbend will pay FSS any amounts payable under the Loan or
Note at the end of the term of the Loan, to the extent that FSS does not have
sufficient income from the Partnership to allow such payment. As consideration,
Riverbend will be entitled to an annual amount equal to the greater of US$3.5
million or 36 percent of the principal and interest then due under the Note
(subject to FSS having suffi cient income received from the Partnership to pay
the same). Under a standby support arrangement, JIL has agreed to provide
Riverbend with funding to enable Riverbend to perform its obligation under the
Swap.
All Relevant Revenues (before deduction of tax) received by and belonging to FSS
shall on the date received be paid or placed into a specified account save as
permitted by the Agreement, FSS may only withdraw amounts from a specified
account to pay any tax arising on the Relevant Revenues.
The order of payment under the Note is as follows:
(i) first, FSS shall pay JIL all unpaid Default interest due under the Note,
if any, to the full extent of available revenues received by FSS in connection
with a defined source ("Relevant Revenues"); and then
(ii) second, of any Relevant Revenues remaining after the payment under
subsection (i) above, FSS shall pay JIL all unpaid interest Note to the full
extent of available Relevant Revenues; and then
(iii) third, of any Relevant Revenues remaining after the payments under
subsections (i) and (ii) above ("Remaining Relevant Revenues"), the Borrower
shall pay:
* 33% (thrity-three per cent) of such Remaining Relevant Revenues to JIL to make a
repayment of principal on the Note up to the remaining unpaid principal on the
Note at the date of such payment, and
* up to 67% (sixty-seven per cent) of such Remaining Relevant Revenues to a third
party approved in advance by JIL, for the sole purpose of hedging FSS's risk
under the Agreement and the Note, up to the full amount of such payments then
due under any such hedging arrangements; and then
(iv) fourth, any Relevant Revenues remaining after the payments under
subsections (i), (ii) and (iii) above shall be paid into and held in a specified
account to make payments under the Note and any hedging arrangements approved by
JIL in future years.
+-----+----------------------------------------------------------------+---------+
| (g) | Directors' Fees | |
+-----+----------------------------------------------------------------+---------+
| | | 2008 |
+-----+----------------------------------------------------------------+---------+
| | | USD |
+-----+----------------------------------------------------------------+---------+
| Lord Daniel Brennan | 203,490 |
+----------------------------------------------------------------------+---------+
| Richard Battey | 121,953 |
+----------------------------------------------------------------------+---------+
| Kermit Birchfield | 137,722 |
+----------------------------------------------------------------------+---------+
| | | |
+-----+----------------------------------------------------------------+---------+
| | | 463,165 |
+-----+----------------------------------------------------------------+---------+
| | | |
+-----+----------------------------------------------------------------+---------+
No pension contributions were paid or were payable on behalf of the Directors.
Lord Daniel Brennan has an interest in 400,000 shares under a Share Option
Agreement, details of which were disclosed in the Admission Document. These have
been valued at US$27,828 for which a provision has been made.
The other Directors have no beneficial interest in the share capital of the
Company.
(h) Cenkos Warrants
Cenkos Securities plc has an interest in 800,000 shares under a Deed of Warrant
Grant at a price of 130p exercisable until 21 December 2012. These have been
valued at $246,906 for which a provision has been made.
11. FUNCTIONAL AND PRESENTATION CURRENCY / EXCHANGE RATES
The financial statements are presented in United States Dollar ("US$") which is
also the Company's functional currency. The following rate was applicable as at
31 December 2008.
+-----+--------------------------------------------------------------+----------+
| | | 2008 |
+-----+--------------------------------------------------------------+----------+
| | | USD |
+-----+--------------------------------------------------------------+----------+
| | | |
+-----+--------------------------------------------------------------+----------+
| | | Closing |
| | | rate |
+-----+--------------------------------------------------------------+----------+
| Great Britain pounds (GBP) | 1.4578 |
+--------------------------------------------------------------------+----------+
| 12. | SHARE CAPITAL | |
+-----+--------------------------------------------------------------+----------+
As at 31 December 2008:
Authorised share capital: Unlimited number of ordinary shares of no par value.
Issued share capital: 80,000,000 shares were issued at a premium of GBP1 per
share.
The Company's Capital is represented by Ordinary Shares of no par value and
share premium. Each share carries one vote and is entitled to dividends when
declared. The relevant movements on capital are shown on the Consolidated
Statement of Changes in Equity.
The Company has authority to make market purchases of up to 14.99 percent of its
own issued Ordinary Shares. This authority will expire on the earlier of 18
months from the date of grant of the authority and the conclusion of the first
annual general meeting of the Company. A renewal of the authority to make
purchases of Ordinary Shares will be sought from Shareholders at each annual
general meeting of the Company. The timing of any purchases will be decided by
the Board.
The Share Premium Reserve of the Company was cancelled on 25 January 2008.
13. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES
The Company's activites expose it to a variety of financial risks: market risk
(including price risk, currency risk, fair value interest rate risk and cash
flow interest rate risk), credit risk and liquidity risk.
The Company's overall risk management programme seeks to maximise the returns
derived for the level of risk to which the Company is exposed and seeks to
minimise potential adverse effects on the Company's financial performance.
All investments in legal claims and loans to the law firm present a risk of loss
of capital, the maximum loss of capital is limited to the fair value.
The management of these risks is carried out by the Manager under policies
approved by the Board of Directors. The Board provides written principles for
overall risk management, as well as written policies covering specific areas
such as foreign exchange risk, interest rate risk, credit risk and investment of
excess liquidity.
The Company uses different methods to measure and manage the various types of
risk to which it is exposed, these methods are explained below.
Market risk
i. Price risk
There is no established market for the Company's assets. The Manager's
assessment of the quantum and timing of returns is subjective and based on the
Manager's experience and due diligence. The estimates of the outcome and
financial effect on the Company of the assets from which respective effective
interest rates are derived is determined by the judgement of the Manager. In
coming to its best estimate of the effective interest rates on the assets, the
Manager has estimated the probability, timing and quantum of particular
outcomes. The respective effective interest rates on non-fixed income
investments are then derived as the mean internal rate of return from a
Monte-Carlo type simulation of expected outcomes. Based on the Manager's
valuation models, the table below presents a sensitivity analysis of the
Company's overall income as at 31 December 2008 assuming each non fixed-income
investment returns respectively the minimum expected return, a return of one
standard deviation less than expected, the expected return, one standard
deviation in excess of expected and the maximum return.
Due to the anticipated lack of correlation of asset returns, the volatility
represented by this analysis would not be expected to be representative of the
volatility of the entire portfolio.
+----------------+----------------+------------+-------+------------+------------+
| | Minimum | -1 Std DEV | Mean | +1 Std | Maximum |
| | | | | Dev | |
+----------------+----------------+------------+-------+------------+------------+
| Effect on | ($25,325,544) ($3,630,337) | - | $2,681,141 | $5,340,700 |
| Income | | | | |
+----------------+----------------+------------+-------+------------+------------+
ii. Foreign Currency Risk
Foreign currency risk is the risk that the value of a financial instrument will
fluctuate because of changes in foreign exchange rates.
The Group's policy is not to manage the Group's exposure to foreign exchange
movements (both monetary and non-monetary) by entering into any foreign exchange
hedging transactions.
Currency exposure
The Company holds assets denominated in currencies other than the US dollar, the
functional currency. It is therefore exposed to currency risk, as values of the
assets denominated in other currencies will fl uctuate due to changes in
exchange rates. The Company may hedge future non-US Dollar investments back into
the functional currency.
As at 31 December 2008 a proportion of the net financial assets of the Company
are denominated in currencies other than USD as follows:
+-------------------------------------------------------------+-------------+
| | 2008 |
+-------------------------------------------------------------+-------------+
| | USD |
+-------------------------------------------------------------+-------------+
| USD | 145,443,828 |
+-------------------------------------------------------------+-------------+
| Sterling | 4,293,659 |
+-------------------------------------------------------------+-------------+
| | |
+-------------------------------------------------------------+-------------+
| | 152,737,487 |
+-------------------------------------------------------------+-------------+
| | |
+-------------------------------------------------------------+-------------+
At 31 December 2008, if exchanges rates had moved by 5% with all other variables
remaining constant, the change in net assets attributable to holders of ordinary
shares for the period would amount to approximately +/- USD 352,880.
iii. Cash flow and fair value interest rate risk
Interest rate risk arises from the effects of fluctuations in the prevailing
levels of market interest rates on the fair value of financial assets and
liabilities and future cash flows. The Company holds fixed and variable rate
interest securities that expose the Company to fair value interest rate risk.
The Company is exposed to interest rate risk related to its cash balances as set
out below. The Company does not actively manage this risk as it invests only in
low risk securities.
+------------------------------+------------------------------+----------+------------+----------+----------+----------+----------+----------+
| | Fixed | | Variable | | Non | | | |
| | | | | | interest | | | |
+------------------------------+------------------------------+----------+------------+----------+----------+----------+----------+----------+
| 31 December 2008 | interest | | Interest | | bearing | | Total | |
+------------------------------+------------------------------+----------+------------+----------+----------+----------+----------+----------+
| Assets | USD | | USD | | USD | | USD | |
+ +------------------------------+----------+------------+----------+----------+----------+----------+----------+
| | | | | | | | | |
+------------------------------+------------------------------+----------+------------+----------+----------+----------+----------+----------+
| Available for sale financial | | | 14,118,352 | 2,400,005 | 16,518,357 | |
| assets | | | | | | |
+------------------------------+------------------------------+----------+------------+---------------------+---------------------+----------+
| Loans and receivables | - | | 53,433,408 | - | 53,433,408 | |
+------------------------------+------------------------------+----------+------------+---------------------+---------------------+----------+
| Other receivables and | - | | - | 273,785 | 273,785 | |
| prepayments | | | | | | |
+------------------------------+------------------------------+----------+------------+---------------------+---------------------+----------+
| Cash and cash equivalents | 20,108,175 | 45,903,808 | 16,499,954 | 82,511,937 | |
+------------------------------+------------------------------+-----------------------+---------------------+---------------------+----------+
| | | | | | | | | |
+------------------------------+------------------------------+----------+------------+----------+----------+----------+----------+----------+
| Total Assets | 20,108,175 | 113,455,568 | 19,173,744 | 152,737,487 | |
+------------------------------+------------------------------+-----------------------+---------------------+---------------------+----------+
| Liabilities | | | | | | | | |
+ +------------------------------+----------+------------+----------+----------+----------+----------+----------+
| | | | | | | | | |
+------------------------------+------------------------------+----------+------------+----------+----------+----------+----------+----------+
| Other payables | - | | - | 383,972 | 383,972 | |
+------------------------------+------------------------------+----------+------------+---------------------+---------------------+----------+
| Total Liabilities | | | | | | | | |
+ +------------------------------+----------+------------+----------+----------+----------+----------+----------+
| | - | | - | 383,972 | 383,972 | |
+------------------------------+------------------------------+----------+------------+---------------------+---------------------+----------+
| Total interest sensitivity | | | | | | | | |
| gap | | | | | | | | |
+ +------------------------------+----------+------------+----------+----------+----------+----------+----------+
| | 20,108,175 | 113,455,568 | 18,789,772 | 152,353,515 | |
+------------------------------+------------------------------+-----------------------+---------------------+---------------------+----------+
| | | | | | | | | |
+------------------------------+------------------------------+----------+------------+----------+----------+----------+----------+----------+
At 31 December 2008, if interest rates had moved by 75 basis points with all
other variables remaining constant, the change in net assets attributable to
holders of ordinary shares for the period would amount to approximately +/-USD
345,510, arising substantially from the cash and cash equivalents.
Credit risk
The Company is exposed to credit risk, which is the risk that a counterparty
will be unable to pay amounts in full when they fall due.
The main concentration to which the Company is exposed arises from the Company's
loan to FSS. The Company is also exposed to counterparty credit risk on trading
financial assets available for sale, cash and cash equivalents and other
receivables.
In accordance with the Company's policy, the Manager monitors the Company's
credit position on a daily basis, and the Board of Directors reviews it on a
quarterly basis.
The Company is also exposed to material credit risk in respect of the
investments and cash and cash equivalents. The credit risk of the cash and cash
equivalents is mitigated as all cash is placed with reputable banking
institutions with a sound credit rating. The maximum credit risk exposure is
limited to the carrying amount of financial assets recognised at the Balance
Sheet date, which amounted to USD 152,737,487.Management assess the risk of
exposure to the general banking system, and specific banks on a continual basis
and invest cash in US government securities when there is perceived risk to
principal.
Liquidity Risk
The Company is exposed to liquidity risk. The investments are acquisitions of
claims, as well as loans to lawyers to fund participation in claims on a
contingency fee basis, and therefore require significant capital contributions
with little or no immediate return and no guarantee of return or repayment. The
market for such investments is not active and cash realisation of capital is
only expected in the long-term. In the opinion of the Directors the current
liquidity risk at 31 December 2008 is low as cash and cash equivalents exceed
unmatched liabilities or other contractual commitments.
+--------------------------------+---------+-+---------+-+---------+-+---------+
| Maturity Analysis | | | | | | | |
+--------------------------------+---------+-+---------+-+---------+-+---------+
| 31 December 2008 | | | | | | | |
+--------------------------------+---------+-+---------+-+---------+-+---------+
| Other payable | < 3 | | < 6 | | < 12 | | Total |
| | months | | months | | months | | |
+--------------------------------+---------+-+---------+-+---------+-+---------+
| Sundry creditors | 46,700 | 178,663 | | - | 225,363 |
+--------------------------------+---------+-----------+-+---------+-----------+
| Legal and Professional fees | - | 43,734 | | - | 43,734 |
+--------------------------------+---------+-----------+-+---------+-----------+
| Audit fees | - | 114,875 | | - | 114,875 |
+--------------------------------+---------+-----------+-+---------+-----------+
| | | | | | | | |
+--------------------------------+---------+-+---------+-+---------+-+---------+
| Total | 46,700 | 337,272 | | - | 383,972 |
+--------------------------------+---------+-----------+-+---------+-----------+
| | | | | | | | |
+--------------------------------+---------+-+---------+-+---------+-+---------+
Capital risk management
The capital of the Company is represented by the net assets attributable to
holders of ordinary shares. The Company's objective when managing capital is to
safeguard the Company's ability to continue as a going concern in order to
provide returns for shareholders and benefits for other stakeholders and to
maintain a strong capital base to support the development of the investment
activites of the Company.
The Company is closed-ended and therefore the capital risk is reduced as
shareholder funds are locked in until the closure of the Company.
Fair value estimation
The fair value of financial assets and liabilities that are not traded in an
active market is determined by using valuation techniques.
The carrying value less impairment provision of other receivables and payables
is assumed to approximate their fair value. The fair value of fi nancial
liabilities for disclosure purpose is not discounted as the Company does not
expect material difference.
14. POST BALANCE SHEET EVENTS
Fundraising
At an Extraordinary General Meeting held on 26 March 2009 the Company approved
the issue of 30,701,754 new ordinary shares of no par value at GBP1.14 per
share. This issue raised GBP32.97 million after payment of all issue expenses
and funds were received on 6 April 2009. The funds are to be deployed in making
further investments in claims. The new shares issued rank "pari passu" with the
existing shares in issue except in respect of the dividend to be paid on 24
April 2009 and noted below.
Dividend
The Directors proposed a dividend of 4.6p per share on 3 March 2009. The ex date
was 1 April 2009, the record date was 3 April 2009 and the dividend was paid on
24 April 2009. This dividend was paid on those shares in issue prior to the fund
raising mentioned above.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR EAXLEDAENEFE
Juridica (LSE:JIL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Juridica (LSE:JIL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
